AzTrials
AzTrials

Sedentary LifestyleNCT03560544

The Effect of Breaking up Sitting in the Workplace on Cardiometabolic Risk and Worker Productivity

A study testing Breaking up sitting in people with Sedentary Lifestyle, run by University of Bedfordshire at 2 sites in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This pilot randomized controlled trial (RCT) will examine the effect of a tailored workplace intervention based on interrupting sitting on work productivity, well-being and cardio-metabolic risk in office workers. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Sedentary Lifestyle
What is being tested?
Breaking up sitting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
2 sitesUnited Kingdom
Study dates
25 Jun 2018to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Full-time office employees from any ethnic background, PC/Android phone users, and recruited from two different work sites.

Who cannot join

  • Pregnancy
  • History of musculoskeletal complaint
  • Non-ambulatory
  • Having a planned holiday that would mean they would not be at work for more than two weeks during the 8-week intervention period.

Trial locations and contacts

2 sites in 1 country.

United Kingdom2 sites
  • Bedford Borough Council

    Bedford, Bedfordshire, MK42 9AP

  • University of Bedfordshire

    Luton, Bedfordshire, LU1 3JU

Other trials in United Kingdom

About this study

Official title: Pilot Study of a Tailored Intervention to Break up Sitting in the Workplace on Cardiometabolic Risk and Worker Productivity

This pilot randomized controlled trial (RCT) will examine the effect of a tailored workplace intervention based on interrupting sitting on work productivity, well-being and cardio-metabolic risk in office workers. The experimental group in the 8-week intervention will be prompted to alternate between sitting and standing while working. The ratio between sitting and standing will begin at 3:1 (two hours per day in an eight-hour day) and increase to 1:1 (four hours per day in an eight-hour day) by the end of the second week of the eight-week intervention.

Being tested
Breaking up sitting
Medical subject headings
Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Breaking up sittingBehavioural

    A three-part behaviour change intervention, including:

    1. Supportive organisational culture and knowledge of consequence of prolonged sitting
    2. Environmental Modification
    3. Behavioural Changes
Study groups in NCT03560544
Study groupRoleWhat they receive
Breaking up sitting timeExperimentalA behaviour-change intervention to break up prolonged sitting in the workplace
Receives: Behavioral: Breaking up sitting
ControlNo interventionThe participants in the control group will continue their daily activities as normal without any form of information about the intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in sitting time (objective)

    Evaluation of change in sitting time in the workplace using wearable accelerometers (ActivPAL3; PAL Technologies Ltd., Glasgow, UK). The ActivPAL will be worn on the right thigh.

    Measured: Change from baseline sitting time at 8 weeks

  2. Change in physical activity level (objective)

    Evaluation of physical activity time in the workplace using wearable accelerometers (ActivPAL3; PAL Technologies Ltd., Glasgow, UK). The ActivPAL will be worn on the right thigh.

    Measured: Change from baseline physical activity level at 8 weeks

  3. Change in sitting time (subjective)

    The International Physical Activity Questionnaire (IPAQ) will be used to provide a subjective measure of sitting. The scale provides a measure of reported sitting time in minutes.

    Measured: Change from baseline sitting time at 8 weeks

  4. Change in physical activity level (subjective)

    The International Physical Activity Questionnaire (IPAQ) will be used to provide a subjective measure of physical activity level. The scale provides a measure of reported sitting time in minutes for each of three types of physical activity (vigorous, moderate, and walking).

    Measured: Change from baseline physical activity level at 8 weeks

Secondary outcomes (15)
  1. Absenteeism

    Participants will be asked to respond to questions on the Gaudine and Gregory questionnaire on unsanctioned absence. Self-reported absenteeism will be calculated by adding the number of days reported for all the three questions.

    Measured: Change from baseline absenteeism at 8 weeks

  2. Presenteeism

    Presenteeism will be measured using Work Limitations Questionnaire (WLQ). The WLQ requires employees to self-report their level of difficulty (or ability) to perform 25 specific job demands in the last 2 weeks. Answers generated for the 25 items will be grouped into four work limitation scales including Time Management; Physical Demands; Mental/Interpersonal and Output Demands. The scores for each subscale range from 0-100%, with 0 equivalent to no limitation and 100 equivalent to complete limitation.

    Measured: Change from baseline presenteeism at 8 weeks

  3. Ecological momentary assessment (EMA)

    Participants will be prompted at random four times between 9am to 5pm from Monday to Friday to complete a short questionnaire which will only take them 60 seconds to complete whilst in sitting position, standing and /or in walking position to enter their level of productivity.

    Measured: Eight weeks

  4. Height

    Measurement of height

    Measured: Once at baseline

  5. Change in weight

    Measurement of weight

    Measured: Change from baseline weight at 8 weeks

  6. Change in waist circumference

    Measurement waist circumference

    Measured: Change from baseline waist circumference at 8 weeks

  7. Blood pressure

    Systolic and diastolic blood pressure on the right arm after resting for at least 10 min in a seated position using an automated blood pressure monitor (Omron HEM705 CP, Omron Healthcare UK Limited, Milton Keynes, UK).

    Measured: Change from baseline blood pressure at 8 weeks

  8. Change in fasting total cholesterol

    Blood samples will be collected in capillary tubes after an overnight fast using a finger prick method with lancet. Measures of total cholesterol will be made.

    Measured: Change from baseline fasting total cholesterol at 8 weeks

  9. Change in fasting high-density lipoprotein

    Blood samples will be collected in capillary tubes after an overnight fast using a finger prick method with lancet. Measures of high-density lipoprotein will be made.

    Measured: Change from baseline fasting high-density lipoprotein at 8 weeks

  10. Change in fasting triglycerides

    Blood samples will be collected in capillary tubes after an overnight fast using a finger prick method with lancet. Measures of triglycerides will be made.

    Measured: Change from baseline fasting triglycerides at 8 weeks

  11. Change in fasting blood glucose levels

    Blood samples will be collected in capillary tubes after an overnight fast using a finger prick method with lancet. Measures of blood glucose levels will be made.

    Measured: Change from baseline fasting blood glucose levels at 8 weeks

  12. Stress

    Cohen Perceived Stress questionnaire will be used to assess perception of stress. It primarily evaluates the unpredictability, uncontrollability and overload of an individual's life.

    Measured: Change from baseline stress at 8 weeks

  13. Mood

    The positive and negative affect schedule (PANAS) questionnaire is a 20-item self-report measure of both positive and negative affect.

    Measured: Change from baseline mood at 8 weeks

  14. Mental Wellbeing

    The Warwick-Edinburgh Mental well-being Scale will be used to determine whether mental wellbeing changes. This scale has 14 questions, with each question scored from 1-5, giving a total score from 14-70.

    Measured: Change from baseline mental wellbeing at 8 weeks

  15. Self-efficacy

    A generalised four-point Likert scale questionnaire will be used to measure the self-efficacy of the participants.

    Measured: Change from baseline self-efficacy at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2018
  2. Study start25 Jun 2018
  3. Primary completion30 Sep 2018 (estimated)
  4. Study completion31 Dec 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03560544
Sponsor's protocol ID
IHREC836
Status last verified
Oct 2018
First submitted
11 Apr 2018
Last updated
10 Oct 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Breaking up sitting in people with Sedentary Lifestyle, run by University of Bedfordshire at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in sitting time (objective) (time frame: Change from baseline sitting time at 8 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in